Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement

Preclinical milestone for selection and approval of first compound for lead optimization has been achievedFurther development validates the ...
Frontiers

Tumor-to-Tumor Communication and Metastatic Progression in Prostate Cancer

Most prostate cancers are initially diagnosed as localized disease and can be effectively treated with surgery or radiation therapy. However, a subset of ...

Cue Biopharma, Inc.: Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement

Preclinical milestone for selection and approval of first compound for lead optimization has been achievedFurther development validates the potential intended mechanistic effect of CUE-501 for T cell- ...

Engineers question Wi-Fi industry focus on peak speeds over signal consistency

Stop blaming your walls for bad Wi-Fi — the problem is how we measure speed, not your home layout ...